Allavena P - Search Results

1

COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC).

Bianchi F, Dama E, Di Nicolantonio F, Baldassarre G, Guerriero I, Torchiaro E, Bruno A, Blandino G, Allavena P, Chiarugi P, Sozzi G, D'Incalci M, Normanno N. Bianchi F, et al. Among authors: allavena p. ESMO Open. 2021 Jun;6(3):100165. doi: 10.1016/j.esmoop.2021.100165. Epub 2021 May 27. ESMO Open. 2021. PMID: 34052554 Free PMC article.

2

Natural killer (NK) and lymphokine activated killer (LAK) cell activity in patients (PTS) treated with flavone acetic acid (FAA).

Galligioni E, Quaia M, Spada A, Crivellari D, Favaro D, Sorio R, Talamini R, D'Incalci M, Allavena P, Damia G, et al. Galligioni E, et al. Among authors: allavena p. Ann Oncol. 1991 Feb;2(2):145-50. doi: 10.1093/oxfordjournals.annonc.a057879. Ann Oncol. 1991. PMID: 2054317 Free article. Clinical Trial.

3

Flavone acetic acid antitumour activity against a mouse pancreatic adenocarcinoma is mediated by natural killer cells.

Damia G, Tagliabue G, Allavena P, D'Incalci M. Damia G, et al. Among authors: allavena p. Cancer Immunol Immunother. 1990;32(4):241-4. doi: 10.1007/BF01741707. Cancer Immunol Immunother. 1990. PMID: 2261598 Free PMC article.

4

In vitro and in vivo effects of cisplatin on the generation of lymphokine-activated killer cells.

Allavena P, Pirovano P, Bonazzi C, Colombo N, Mantovani A, D'Incalci M. Allavena P, et al. J Natl Cancer Inst. 1990 Jan 17;82(2):139-42. doi: 10.1093/jnci/82.2.139. J Natl Cancer Inst. 1990. PMID: 2294223

5

Lymphokine-activated killer (LAK) and monocyte-mediated cytotoxicity on tumor cell lines resistant to antitumor agents.

Allavena P, Damia G, Colombo T, Maggioni D, D'Incalci M, Mantovani A. Allavena P, et al. Cell Immunol. 1989 Apr 15;120(1):250-8. doi: 10.1016/0008-8749(89)90192-5. Cell Immunol. 1989. PMID: 2784721

6

IFN-beta partially counteracts inhibition of natural killer activity induced by some antitumor agents.

Allavena P, Giardina G, Sen S, Colella G, Broggini M, D'Incalci M. Allavena P, et al. J Interferon Cytokine Res. 1998 Feb;18(2):87-93. doi: 10.1089/jir.1998.18.87. J Interferon Cytokine Res. 1998. PMID: 9506459

7

Comparison of in vitro and in vivo biological effects of trabectedin, lurbinectedin (PM01183) and Zalypsis® (PM00104).

Romano M, Frapolli R, Zangarini M, Bello E, Porcu L, Galmarini CM, García-Fernández LF, Cuevas C, Allavena P, Erba E, D'Incalci M. Romano M, et al. Among authors: allavena p. Int J Cancer. 2013 Nov;133(9):2024-33. doi: 10.1002/ijc.28213. Epub 2013 May 25. Int J Cancer. 2013. PMID: 23588839

8

Trabectedin: A drug from the sea that strikes tumor-associated macrophages.

Allavena P, Germano G, Belgiovine C, D'Incalci M, Mantovani A. Allavena P, et al. Oncoimmunology. 2013 Jun 1;2(6):e24614. doi: 10.4161/onci.24614. Epub 2013 Apr 16. Oncoimmunology. 2013. PMID: 23894721 Free PMC article.

9

Trabectedin and plitidepsin: drugs from the sea that strike the tumor microenvironment.

Galmarini CM, D'Incalci M, Allavena P. Galmarini CM, et al. Among authors: allavena p. Mar Drugs. 2014 Jan 27;12(2):719-33. doi: 10.3390/md12020719. Mar Drugs. 2014. PMID: 24473171 Free PMC article. Review.

10

Trabectedin, a drug acting on both cancer cells and the tumour microenvironment.

D'Incalci M, Badri N, Galmarini CM, Allavena P. D'Incalci M, et al. Among authors: allavena p. Br J Cancer. 2014 Aug 12;111(4):646-50. doi: 10.1038/bjc.2014.149. Epub 2014 Apr 22. Br J Cancer. 2014. PMID: 24755886 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters